EyePoint Pharmaceuticals has successfully priced its underwritten public offering at $12.00 per share, aiming to raise approximately $150 million in gross proceeds. This significant capital infusion...
An Ottawa woman has dedicated over a decade to providing warmth and comfort to cancer patients by crocheting and donating blankets. Ruth Shevel recently achieved a...
The Manitoba government is taking significant steps to address health care staffing shortages by inviting over 300 temporary foreign workers to apply for permanent residency in...
The number of Nova Scotians registered as needing a family doctor has decreased significantly. As of October 1, 2023, the Nova Scotia Health Authority (NSHA) reported...
When Calgary entrepreneur Justin Sather learned of a promising treatment for dry age-related macular degeneration (dry AMD)—the leading cause of vision loss among adults in Canada—he...
Kingston Health Sciences Centre (KHSC) has received approval from Health Canada to commence the first clinical trials in the country focused on microdosing psilocybin, the psychedelic...
Kingston Health Sciences Centre (KHSC) has received approval from Health Canada to conduct pioneering clinical trials focused on the microdosing of psilocybin, the psychedelic compound found...
The GPS Parent Series is hosting a webinar titled “Untangling Teen Challenges Today: The Epidemic of Stress and Anxiety” featuring clinical psychologist and author Lisa Damour....
Johnson & Johnson is set to release its earnings report for the third quarter of 2023 on October 24, 2023. This report will provide critical insights...
MannKind Corporation has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental marketing application for Afrezza, an inhalation powder of human insulin....
